© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Oncology
Reframing Race and Cancer
May 12, 2022
Research and discussion about the high cancer rates among Black Americans used to be dominated by genetics and the search for biological differences. Now attention has shifted to the social determinants of health.
Has the Pendulum Swung Too Far Against the Use of Opioids?
April 20, 2022
Patients with cancer who have a poor prognosis may face obstacles in accessing critical pain medications.
Cancer Mortality is Decreasing in the U.S.
March 16, 2022
The American Cancer Society’s 2022 statistical report shows that the 30-year trend is continuing.
Quality of Life and the Typical Patient Journey With UF
February 21, 2022
Dr Al-Hendy discusses the impact UF has on a patient’s life and their typical patient journey through the healthcare system.
Uterine Fibroids Background
February 21, 2022
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP, provides a comprehensive background on uterine fibroids, explaining everything from clinical burden to symptoms.
Biden Relaunches Cancer Moonshot to “End Cancer as We Know It”
February 03, 2022
Biden is reviving the program he headed as vice president with the goal of reducing the cancer mortality rate and improving the experience of patients and their loved ones.
VA Hospital Improves Timeliness of HCC Diagnosis, Treatment With Electronic Tracking System
January 25, 2022
The introduction of an electronic tracking system decreased the time from hepatocellular carcinoma (HCC) diagnosis to treatment by more than a month.
Billions Flowing into the Cancer Immunotherapy Market
January 24, 2022
The global cancer immunotherapy market is set to grow at a compound annual growth rate, or CAGR, of 12.6% to $277.1 billion by 2030.
Immunotherapy, Precision Medicine are Coming on Strong in Oncology
January 12, 2022
But the future of value-based care in oncology is uncertain with no certain successor to the Oncology Care Model in sight.
With High Deductible Health Plans, Cancer Patients are Paying More, Study Finds
December 22, 2021
Patients with a variety of cancers spent much more money out of their own pocket than those in traditional plans. Some may be delaying treatment due to higher costs.